Kieran Gallahue, Chief Executive Officer at RESMED INC (RMD), sold 5,000 shares at $64.32 ($322K) on 2010-06-07, disclosed to the SEC on 2010-06-09.
Scheduled sale ($322k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | BUY | 2017-02-06 | $270K | — | Filing → |
| EW | BUY | 2016-12-01 | $254K | — | Filing → |
| XENT | BUY | 2016-05-17 | $101K | — | Filing → |